Related Experiment Video
Updated: Nov 20, 2025

08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
15.3K
Structure and regulation of human phospholipase D
Forrest Z Bowling1, Michael A Frohman2, Michael V Airola1
1Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
Advances in Biological Regulation
|January 26, 2021
Summary
Mammalian phospholipase D (PLD) produces phosphatidic acid, vital for cell functions. This review covers PLD structures, inhibitors, and its regulation by proteins and lipids, highlighting its pharmaceutical potential.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Mammalian phospholipase D (PLD) generates phosphatidic acid, a crucial lipid secondary messenger.
- Phosphatidic acid regulates diverse cellular processes, including metabolism, migration, and exocytosis.
- PLD is a significant pharmaceutical target due to its broad cellular involvement.
Purpose of the Study:
- To review the structural, biochemical, and regulatory aspects of mammalian phospholipase D (PLD).
- To discuss recent advancements in understanding PLD structures, small-molecule inhibitors, and regulatory mechanisms.
- To highlight the potential of PLD as a pharmaceutical target.
Main Methods:
- Structural analysis of human PLD1 and PLD2 crystal structures.
- Review of identified small-molecule inhibitors targeting PLD.
- Analysis of literature on cellular proteins and lipids regulating PLD activity.
Main Results:
- Detailed discussion of human PLD1 and PLD2 crystal structures.
- Overview of the development and characterization of PLD-specific pharmacological inhibitors.
- Identification and discussion of key effector proteins and lipids that regulate PLD activity.
Conclusions:
- Mammalian PLD is a well-characterized enzyme with critical roles in cellular signaling.
- Structural insights and inhibitor development position PLD as a promising therapeutic target.
- Understanding PLD regulation is key to developing targeted pharmacological interventions.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
9.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.6K
Protein Kinases and Phosphatases
14.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.3K
IP3/DAG Signaling Pathway
13.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.5K
Synthesis of Phosphatidylcholine in the ER Membrane
3.7K
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
3.7K
Phosphorylation
53.0K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.0K
Asymmetric Lipid Bilayer
9.1K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
9.1K

